Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aim Immunotech Inc. (AIM) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aim Immunotech Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 946644.
Total stock buying since 2015: $1,994,875.
Total stock sales since 2015: $883.
Total stock option exercises since 2015: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 4,396,903 | $134,560 | 0 | $0 | 0 | $0 |
| 2024 | 726,505 | $199,597 | 4,580 | $883 | 0 | $0 |
| 2023 | 1,709,617 | $550,500 | 0 | $0 | 0 | $0 |
| 2021 | 37,325 | $79,999 | 0 | $0 | 0 | $0 |
| 2020 | 37,581 | $75,001 | 0 | $0 | 0 | $0 |
| 2019 | 81,177 | $276,391 | 0 | $0 | 0 | $0 |
| 2018 | 618,643 | $176,402 | 0 | $0 | 0 | $0 |
| 2017 | 352,907 | $196,444 | 0 | $0 | 0 | $0 |
| 2016 | 413,243 | $136,144 | 0 | $0 | 0 | $0 |
| 2015 | 754,104 | $169,837 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-06 | 210 | $1,719 | 0 | $0 | 0 | $0 |
| 2025-04 | 4,175,359 | $105,971 | 0 | $0 | 0 | $0 |
| 2025-03 | 221,334 | $26,870 | 0 | $0 | 0 | $0 |
| 2024-12 | 33,839 | $7,036 | 4,580 | $883 | 0 | $0 |
| 2024-11 | 332,063 | $64,886 | 0 | $0 | 0 | $0 |
| 2024-09 | 25,000 | $7,675 | 0 | $0 | 0 | $0 |
| 2024-05 | 92,594 | $37,500 | 0 | $0 | 0 | $0 |
| 2024-03 | 243,009 | $82,500 | 0 | $0 | 0 | $0 |
| 2023-11 | 33,861 | $15,000 | 0 | $0 | 0 | $0 |
| 2023-09 | 22,676 | $10,000 | 0 | $0 | 0 | $0 |
| 2023-08 | 23,215 | $15,500 | 0 | $0 | 0 | $0 |
| 2023-07 | 16,950 | $10,000 | 0 | $0 | 0 | $0 |
| 2023-01 | 1,612,915 | $500,000 | 0 | $0 | 0 | $0 |
| 2021-07 | 15,625 | $30,000 | 0 | $0 | 0 | $0 |
| 2021-02 | 21,700 | $49,999 | 0 | $0 | 0 | $0 |
| 2020-12 | 14,535 | $25,000 | 0 | $0 | 0 | $0 |
| 2020-09 | 12,316 | $25,001 | 0 | $0 | 0 | $0 |
| 2020-08 | 10,730 | $25,000 | 0 | $0 | 0 | $0 |
| 2019-06 | 67,777 | $274,033 | 0 | $0 | 0 | $0 |
| 2019-03 | 13,400 | $2,358 | 0 | $0 | 0 | $0 |
| 2018-11 | 45,238 | $9,392 | 0 | $0 | 0 | $0 |
| 2018-10 | 103,500 | $20,710 | 0 | $0 | 0 | $0 |
| 2018-07 | 337,905 | $104,060 | 0 | $0 | 0 | $0 |
| 2018-04 | 132,000 | $42,240 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-13 | Equels Thomas K (CEO & President) | Buy | 107 | 7.70 | 823 |
| 2025-06-12 | Equels Thomas K (CEO & President) | Buy | 103 | 8.70 | 896 |
| 2025-04-11 | Equels Thomas K (CEO & President) | Buy | 1,968,504 | .03 | 49,212 |
| 2025-04-11 | Mitchell William M | Buy | 196,851 | .03 | 4,921 |
| 2025-04-11 | Kellner Ted D | Buy | 1,968,504 | .03 | 49,212 |
| 2025-04-04 | Rodino Peter W Iii (COO, Secretary, Gen. Counsel) | Buy | 500 | .09 | 43 |
| 2025-04-04 | Equels Thomas K (CEO & President) | Buy | 41,000 | .06 | 2,583 |
| 2025-03-05 | Equels Thomas K (CEO & President) | Buy | 50,000 | .14 | 6,750 |
| 2025-03-04 | Equels Thomas K (CEO & President) | Buy | 127,334 | .12 | 15,060 |
| 2024-12-19 | Mitchell William M | Sale | 4,580 | .19 | 883 |
| 2024-12-18 | Equels Thomas K (CEO & President) | Buy | 22,727 | .21 | 4,681 |
| 2024-12-02 | Appelrouth Stewart | Buy | 11,112 | .21 | 2,355 |
| 2024-11-21 | Equels Thomas K (CEO & President) | Buy | 20,000 | .21 | 4,240 |
| 2024-11-20 | Appelrouth Stewart | Buy | 81,953 | .19 | 15,816 |
| 2024-11-20 | Equels Thomas K (CEO & President) | Buy | 145,110 | .19 | 27,915 |
| 2024-09-16 | Equels Thomas K (CEO & President) | Buy | 5,000 | .30 | 1,515 |
| 2024-09-13 | Equels Thomas K (CEO & President) | Buy | 20,000 | .31 | 6,160 |
| 2024-05-06 | Rodino Peter W Iii (COO, Secretary, Gen. Counsel) | Buy | 30,865 | .41 | 12,500 |
| 2024-05-06 | Equels Thomas K (CEO & President) | Buy | 61,729 | .41 | 25,000 |
| 2024-03-21 | Bryan Nancy (Director) | Buy | 38,462 | .39 | 15,000 |
| 2024-03-15 | Appelrouth Stewart | Buy | 90,910 | .33 | 30,000 |
| 2024-03-15 | Rodino Peter W Iii (COO, Secretary, Gen. Counsel) | Buy | 37,879 | .33 | 12,500 |
| 2024-03-15 | Equels Thomas K (CEO & President) | Buy | 75,758 | .33 | 25,000 |
| 2023-11-27 | Equels Thomas K (CEO & President) | Buy | 33,861 | .44 | 15,000 |
| 2023-09-29 | Equels Thomas K (CEO & President) | Buy | 22,676 | .44 | 10,000 |
| 2023-08-25 | Equels Thomas K (CEO & President) | Buy | 8,222 | .67 | 5,500 |
| 2023-08-24 | Equels Thomas K (CEO & President) | Buy | 14,993 | .67 | 10,000 |
| 2023-07-17 | Equels Thomas K (CEO & President) | Buy | 16,950 | .59 | 10,000 |
| 2023-01-03 | Appelrouth Stewart | Buy | 241,938 | .31 | 75,000 |
| 2023-01-03 | Rodino Peter W Iii (COO, Secretary, Gen. Counsel) | Buy | 241,938 | .31 | 75,000 |
| 2023-01-03 | Equels Thomas K (CEO & President) | Buy | 483,873 | .31 | 150,000 |
| 2021-07-16 | Equels Thomas K. (CEO & President) | Buy | 15,625 | 1.92 | 30,000 |
| 2021-02-25 | Appelrouth Stewart (Director) | Buy | 10,638 | 2.35 | 24,999 |
| 2021-02-24 | Equels Thomas K. (CEO & President) | Buy | 11,062 | 2.26 | 25,000 |
| 2020-12-17 | Equels Thomas K. (CEO) | Buy | 14,535 | 1.72 | 25,000 |
| 2020-09-03 | Equels Thomas K. (CEO & President) | Buy | 12,316 | 2.03 | 25,001 |
| 2020-08-21 | Equels Thomas K. (CEO) | Buy | 10,730 | 2.33 | 25,000 |
| 2019-06-27 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 2,632 | 4.37 | 11,501 |
| 2019-06-21 | Appelrouth Stewart (Director) | Buy | 9,677 | 4.03 | 38,998 |
| 2019-06-21 | Rodino Iii Peter W. (Dir Govt Relations/Sectry) | Buy | 8,695 | 4.03 | 35,040 |
| 2019-06-21 | Springate Wayne S (Sr. VP of Operations) | Buy | 5,211 | 4.03 | 21,000 |
| 2019-06-21 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 29,404 | 4.03 | 118,498 |
| 2019-06-21 | Strayer David R (Chief Science/Medical Officer) | Buy | 2,481 | 4.03 | 9,998 |
| 2019-06-21 | Mitchell William M (Director) | Buy | 9,677 | 4.03 | 38,998 |
| 2019-03-19 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 13,400 | .18 | 2,358 |
| 2018-11-30 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 20,000 | .19 | 3,840 |
| 2018-11-05 | Appelrouth Stewart (Director) | Buy | 25,238 | .22 | 5,552 |
| 2018-10-26 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 3,500 | .20 | 710 |
| 2018-10-25 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 100,000 | .20 | 20,000 |
| 2018-07-27 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 34,483 | .29 | 10,000 |
| 2018-07-24 | Appelrouth Stewart (Director) | Buy | 126,000 | .31 | 39,060 |
| 2018-07-23 | Pascale Adam (CFO) | Buy | 32,259 | .31 | 10,000 |
| 2018-07-23 | Springate Wayne S (Sr. VP of Operations) | Buy | 32,259 | .31 | 10,000 |
| 2018-07-23 | Equels Thomas K. (Exec. Vice Chairman/CEO/Pres.) | Buy | 112,904 | .31 | 35,000 |
| 2018-04-27 | Appelrouth Stewart (Director) | Buy | 100,000 | .32 | 32,000 |
| 2018-04-27 | Equels Thomas K. (CEO, President) | Buy | 32,000 | .32 | 10,240 |
| 2017-05-02 | Pascale Adam (CFO) | Buy | 15,873 | .63 | 9,999 |
| 2017-05-02 | Rodino Peter W. Iii (Exec Dir Govt Relations/Secrty) | Buy | 15,873 | .63 | 9,999 |
| 2017-05-02 | Springate Wayne S. (Sr VP of Operations) | Buy | 15,873 | .63 | 9,999 |
| 2017-05-02 | Strayer David R (Chief Science/Medical Officer) | Buy | 7,937 | .63 | 5,000 |
| 2017-04-27 | Equels Thomas K. (CEO, President) | Buy | 72,464 | .69 | 50,000 |
| 2017-04-11 | Equels Thomas K. (CEO, President) | Buy | 200,000 | .50 | 100,000 |
| 2017-02-16 | Pascale Adam (CFO) | Buy | 6,981 | .46 | 3,211 |
| 2017-02-16 | Springate Wayne S. (Sr VP of Operations) | Buy | 8,014 | .46 | 3,686 |
| 2017-02-16 | Strayer David R (Chief Science/Medical Officer) | Buy | 9,892 | .46 | 4,550 |
| 2016-12-22 | Equels Thomas K. (CEO, President) | Buy | 68,493 | .73 | 49,999 |
| 2016-11-01 | Equels Thomas K. (CEO,President) | Buy | 10,000 | 1.00 | 10,000 |
| 2016-08-24 | Appelrouth Stewart (Director) | Buy | 15,750 | 2.21 | 34,807 |
| 2016-07-08 | Equels Thomas K. (CEO, President) | Buy | 48,000 | .12 | 5,664 |
| 2016-07-01 | Equels Thomas K. (CEO,President) | Buy | 56,000 | .12 | 6,664 |
| 2016-06-30 | Equels Thomas K. (CEO,President) | Buy | 56,000 | .12 | 6,720 |
| 2016-06-29 | Equels Thomas K. (CEO,President) | Buy | 59,000 | .12 | 7,080 |
| 2016-03-18 | Equels Thomas K. (CEO,Pres,Exec Vice Chairman) | Buy | 30,000 | .13 | 3,960 |
| 2016-03-11 | Equels Thomas K. (CEO,Pres,Exec Vice Chairman) | Buy | 40,000 | .16 | 6,360 |
| 2016-03-10 | Equels Thomas K. (CEO,Pres,Exec Vice Chairman) | Buy | 30,000 | .16 | 4,890 |
| 2015-08-20 | Carter William A (CEO) | Buy | 25,000 | .18 | 4,500 |
| 2015-08-18 | Carter William A (CEO) | Buy | 25,000 | .18 | 4,550 |
| 2015-08-17 | Carter William A (CEO) | Buy | 25,000 | .18 | 4,550 |
| 2015-08-14 | Equels Thomas K. (CFO, Pres.,Sec., Vice Chairman) | Buy | 50,000 | .18 | 9,000 |
| 2015-08-13 | Equels Thomas K. (CFO, Pres.,Sec., Vice Chairman) | Buy | 29,104 | .18 | 5,238 |
| 2015-04-28 | Carter William A (CEO) | Buy | 100,000 | .24 | 24,200 |
| 2015-04-27 | Equels Thomas K. (CFO, Vice Chairman, Secretary) | Buy | 100,000 | .24 | 24,400 |
| 2015-04-21 | Carter William A (CEO) | Buy | 100,000 | .24 | 24,000 |
| 2015-04-20 | Equels Thomas K. (CFO, Vice Chairman, Secretary) | Buy | 100,000 | .24 | 23,900 |
| 2015-04-17 | Carter William A (CEO) | Buy | 73,681 | .23 | 16,946 |
| 2015-04-16 | Carter William A (CEO) | Buy | 26,319 | .23 | 6,053 |
| 2015-04-15 | Equels Thomas K. (CFO, Vice Chairman, Secretary) | Buy | 100,000 | .23 | 22,500 |
Insider trading activities including stock purchases, stock sales, and option exercises of AIM listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aim Immunotech Inc. (symbol AIM, CIK number 946644) see the Securities and Exchange Commission (SEC) website.